CRN00808: Clinical Trials

7 trials of CRN00808, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated. 3 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 12Completed 2
Phase 32Terminated 2

Follow CRN00808: new trials by email Literature Review of CRN00808 trials Research Report on CRN00808

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
Paltusotine, Placebo - Acromegaly
Phase 3TerminatedCrinetics Pharmaceuticals Inc.1112021-12-172026-07-15
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
Paltusotine, Placebo - Acromegaly
Phase 3TerminatedCrinetics Pharmaceuticals Inc.582021-05-122026-07-15
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
Paltusotine - Acromegaly
Phase 2TerminatedCrinetics Pharmaceuticals Inc.432020-01-292026-07-29
Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers
[14C]-CRN00808, CRN00808 - Healthy Volunteers
Phase 1CompletedCrinetics Pharmaceuticals Inc.112019-09-172020-01-29
An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)
Paltusotine - Acromegaly
Phase 2CompletedCrinetics Pharmaceuticals Inc.472019-03-122025-02-17
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
Paltusotine, Placebo - Acromegaly
Phase 2CompletedCrinetics Pharmaceuticals Inc.132019-03-112025-03-17
Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers
CRN00808, Placebo Oral Solution, Midazolam oral solution - Healthy Volunteers
Phase 1CompletedCrinetics Pharmaceuticals Inc.992017-09-222018-08-29

Conditions studied

Acromegaly (5)

Sponsors

Crinetics Pharmaceuticals Inc. (7)

Countries

Brazil (5)  ·  Hungary (5)  ·  United States (5)  ·  Greece (4)  ·  Poland (4)  ·  Serbia (4)  ·  United Kingdom (4)  ·  Germany (3)  ·  Italy (3)  ·  Argentina (2)  ·  Bulgaria (2)  ·  France (2)  ·  Israel (2)  ·  New Zealand (2)  ·  Slovakia (2)

Top investigators

Jason Lickliter, MBBS PhD (1)

Results publications

PMID 36792844, PMID 35000098

NIH funding

2018 (2), 2019 (1)